Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024年4月4日 - 8:30PM
ビジネスワイヤ(英語)
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company
committed to advancing new medicines for patients with cancer,
today announced the grant of stock options to purchase 35,000
shares of its common stock to four new employees. The awards were
granted pursuant to the Nasdaq inducement grant exception as an
inducement material to the employees’ acceptance of employment with
Verastem Oncology in accordance with Nasdaq Listing Rule
5635(c)(4). The stock options have an exercise price equal to
$11.73 per share, the closing price of Verastem Oncology’s common
stock as reported by Nasdaq on April 1, 2024. The stock options to
purchase 35,000 shares of common stock that were granted to the
four new employees will vest at a rate of twenty-five percent (25%)
on the one-year anniversary of each employee’s date of hire, with
the remaining shares vesting quarterly over the next three (3)
years in equal quarterly amounts, provided the employee continues
to serve as an employee of or other service provider to Verastem
Oncology on each such vesting date.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a
late-stage development biopharmaceutical company committed to the
development and commercialization of new medicines to improve the
lives of patients diagnosed with cancer. Our pipeline is focused on
novel small molecule drugs that inhibit critical signaling pathways
in cancer that promote cancer cell survival and tumor growth,
including RAF/MEK inhibition and FAK inhibition. For more
information, please visit www.verastem.com and follow us on
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240404745728/en/
For Investor and Media Inquiries: Julissa Viana Vice
President, Corporate Communications and Investor Relations
investors@verastem.com or media@verastem.com
Verastem (NASDAQ:VSTM)
過去 株価チャート
から 4 2024 まで 5 2024
Verastem (NASDAQ:VSTM)
過去 株価チャート
から 5 2023 まで 5 2024